Fig. 8

THI outcome for each group (placebo, BBT, TRT, EAE and ADT) in the three monitoring sessions (S2, S3 and S4). This questionnaire outcome is one of four conditions: light, mild, moderate, severe o catastrophic alteration.

THI outcome for each group (placebo, BBT, TRT, EAE and ADT) in the three monitoring sessions (S2, S3 and S4). This questionnaire outcome is one of four conditions: light, mild, moderate, severe o catastrophic alteration.